Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 38.32B | 37.58B | 35.48B | 32.77B | 16.81B | 13.59B |
Gross Profit | 4.89B | 4.83B | 7.43B | 4.62B | -3.00M | -2.98B |
EBITDA | 4.24B | 4.66B | 5.30B | 3.73B | 92.00M | -3.66B |
Net Income | 1.23B | 1.38B | 1.67B | 791.00M | -2.19B | -6.77B |
Balance Sheet | ||||||
Total Assets | 48.14B | 47.05B | 45.32B | 43.34B | 42.54B | 39.48B |
Cash, Cash Equivalents and Short-Term Investments | 8.84B | 8.49B | 8.27B | 8.30B | 7.60B | 5.38B |
Total Debt | 0.00 | 14.23B | 13.95B | 15.17B | 16.69B | 15.38B |
Total Liabilities | 37.60B | 35.46B | 35.61B | 34.86B | 38.05B | 38.10B |
Stockholders Equity | 10.49B | 11.54B | 9.66B | 8.40B | 4.45B | 1.35B |
Cash Flow | ||||||
Free Cash Flow | 499.00M | -6.00M | 895.00M | 2.66B | -700.00M | -3.58B |
Operating Cash Flow | 4.33B | 3.89B | 4.95B | 5.17B | 618.00M | -2.33B |
Investing Cash Flow | -2.81B | -2.33B | -2.98B | -3.44B | -3.02B | -2.34B |
Financing Cash Flow | -1.15B | -1.45B | -2.07B | -2.27B | 2.87B | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $25.86B | 7.26 | 33.57% | ― | 5.31% | 35.95% | |
78 Outperform | $32.38B | 8.79 | 27.52% | 1.21% | 4.91% | -27.21% | |
74 Outperform | $10.11B | 7.35 | 12.68% | 4.03% | 6.06% | -11.01% | |
73 Outperform | $29.69B | 18.14 | 22.41% | 1.63% | 3.12% | -13.82% | |
68 Neutral | $18.33B | 38.19 | 5.63% | 2.24% | 3.26% | 27.77% | |
64 Neutral | $7.44B | 12.95 | -21.27% | ― | 1.92% | 36.07% | |
63 Neutral | kr63.91B | 12.59 | 1.54% | 10.66% | 0.04% | -3.90% |